Changeflow GovPing Healthcare & Life Sciences Conjugated Oligonucleotide Compounds for Therap...
Routine Notice Added Draft

Conjugated Oligonucleotide Compounds for Therapeutic Use

Email

Summary

The USPTO has published a new patent application (US20260085314A1) for conjugated oligonucleotide compounds, methods of making them, and their therapeutic uses. The application was filed on May 16, 2025, by inventors Ahmad Ali Mortazavi, Viviana Mannella, and Muthusamy Jayaraman.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260085314A1, titled 'Conjugated Oligonucleotide Compounds, Methods of Making and Uses Thereof.' The application details novel conjugated oligonucleotide compounds suitable for therapeutic use, along with methods for their creation and application in treating various diseases and conditions. The filing date was May 16, 2025.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may inform research and development strategies for pharmaceutical and biotechnology companies. Companies operating in these sectors should be aware of this filing for competitive intelligence and potential licensing opportunities.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

CONJUGATED OLIGONUCLEOTIDE COMPOUNDS, METHODS OF MAKING AND USES THEREOF

Application US20260085314A1 Kind: A1 Mar 26, 2026

Inventors

Ahmad Ali MORTAZAVI, Viviana MANNELLA, Muthusamy JAYARAMAN

Abstract

The present invention relates to novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.

CPC Classifications

C12N 15/113 C12N 2310/14 C12N 2310/313 C12N 2310/315 C12N 2310/317 C12N 2310/351 C12N 2320/32 C12N 2330/30

Filing Date

2025-05-16

Application No.

19211026

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085314A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Therapeutic Use
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Intellectual Property Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!